康健國際醫療(03886.HK)發佈盈喜:上半年預盈2000萬港元-2500萬港元
格隆匯8月9日丨康健國際醫療(03886.HK)公佈,預期截至2021年6月30日止六個月,集團將錄得未經審核綜合溢利介乎約2000萬港元至2500萬港元,而集團截至2020年6月30日止六個月錄得未經審核綜合虧損約8770萬港元。
由未經審核綜合虧損扭虧為盈至未經審核綜合溢利乃主要由於以下各項的綜合影響:(i)截至2021年6月30日止六個月的(a)醫療服務;(b)內地醫院管理及相關服務;及(c)2019冠狀病毒病檢測服務的需求增加,因此集團截至2021年6月30日止六個月錄得收入增加,而截至2020年6月30日止六個月集團錄得收入約4.37億港元;(ii)集團的投資物業於截至2021年6月30日止六個月錄得公平值收益,而集團的投資物業於截至2020年6月30日止六個月錄得公平值虧損約4230萬港元;(iii)於截至2021年6月30日止六個月錄得應占聯營公司溢利,而截至2020年6月30日止六個月錄得應占聯營公司虧損約940萬港元;及(iv)截至2021年6月30日止六個月相關資產錄得的減值虧損增加,而截至2020年6月30日止六個月相關資產錄得的減值虧損約為990萬港元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.